Correlation between broth microdilution and disk diffusion methods for antifungal susceptibility testing of caspofungin, voriconazole, amphotericin B, itraconazole and fluconazole against Candida glabrata

Journal of Microbiological Methods

Volumn 82, Issue 2, 2010, Pages 136-140

  Kiraz, N ^a   Dag, I ^a   Oz, Y ^a   Yamac, M ^a   Kiremitci, A ^a   Kasifoglu, N ^a  

^a ESKISEHIR OSMANGAZI UNIVERSITY   (Turkey)

Author keywords

Antifungal; Antifungal susceptibility method; Azole resistance; Broth microdilution; Candida glabrata; Disk diffusion

Indexed keywords

AMPHOTERICIN B; CASPOFUNGIN; FLUCONAZOLE; ITRACONAZOLE; VORICONAZOLE; ANTIFUNGAL AGENT;

ANTIFUNGAL ACTIVITY; ANTIFUNGAL RESISTANCE; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; BROTH DILUTION; CANDIDA GLABRATA; CONTROLLED STUDY; CORRELATIONAL STUDY; DISK DIFFUSION; FUNGUS ISOLATION; IN VITRO STUDY; INTERMETHOD COMPARISON; NONHUMAN; PRIORITY JOURNAL; COMPARATIVE STUDY; DRUG EFFECTS; EVALUATION STUDY; HUMAN; MICROBIAL SENSITIVITY TEST; PROCEDURES;

ANTIFUNGAL AGENTS; CANDIDA GLABRATA; HUMANS; MICROBIAL SENSITIVITY TESTS;

CANDIDA ALBICANS; CANDIDA GLABRATA;

EID: 77954085976     PISSN: 01677012     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mimet.2010.05.002     Document Type: Article

References (30)

1. Alexander B., Byrne T.C., Smith K.L., Hanson K.E., Anstrom K.J., Perfect J.R., et al. Comparative evaluation of Etest and Sensititre YeastOne panels against the Clinical and Laboratory Standards Institute M27-A2 reference broth microdilution method for testing Candida susceptibility to seven antifungal agents. J. Clin. Microbiol. 2007, 45:698-706.
2. Arend S.M., Kuijper E.J., Vaal B.J., Fijter J.W., Wout J.W. Successful treatment of fungus balls due to fluconazole-resistant Candida sake obstructing ureter stents in a renal transplant patient. Eur. J. Clin. Microbiol. Infect. Dis. 2006, 25:43-45.
3. Arendrup M., Lundgren B., Jensen I.M., Hansen B.S., Frimodt-Møller N. Comparison of Etest and a tablet diffusion test with the NCCLS broth microdilution method for fluconazole and amphotericin B susceptibility testing of Candida isolates. J. Antimicrob. Chemother. 2001, 47:521-526.
4. Basurto-Kuba E., Figueroa R.B.G., Santibanez J.A., Bonifaz-Trujillo A. Candida glabrata: an emergent opportunist in vulvovaginitis. Cir. Cir. 2009, 77:423-427.
5. Buchta V., Vejsova M., Vale-Silva L.A. Comparison of disk diffusion test and Etest for voriconazole and fluconazole susceptibility testing. Folia Microbiol. 2008, 53:153-160.
6. Canton E., Espinel-Ingroff A., Peman J. Trends in antifungal susceptibility testing using CLSI reference and commercial methods. Expert Rev. Anti-Infect. Ther. 2009, 7:107-119.
7. Carrillo-Muñoz A.J., Quindós G., del Valle O., Santos P., Giusiano G., Ezkurra P.A., et al. Activity of caspofungin and voriconazole against clinical isolates of Candida and other medically important yeasts by the CLSI M-44A disk diffusion method with neo-sensitabs tablets. Chemotherapy 2008, 54:38-42.
8. Castaño I., Cormack B., Peñas A. Virulence of the opportunistic fungal pathogen Candida glabrata. Rev. Latinoam. Microbiol. 2006, 48:66-69.
9. Clinical Laboratory Standards Institute Method for Antifungal Disk Diffusion Susceptibility Testing in Yeasts, Approved Guideline, Vol, M-44-A 2002, CLSI, Wayne, PA.
10. Clinical Laboratory Standards Institute (CLSI) Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeast; Approved Standard-Third Edition. CLSI document M27-A3 2008.
11. Dias A.L.T., Matsumoto F.E., Melhem M.S.C., Silva E.G., Auler M.E., Siqueira A.M., et al. Comparative analysis of Etest and broth microdilution method (AFST-EUCAST) for trends in antifungal drug susceptibility testing of Brazilian Cryptococcus neoformans isolates. J. Med. Microbiol. 2006, 55:1693-1699.
12. Diekema D.J., Meser S.A., Hollis R.J., Boyken L.B., Tendolkar S., Kroeger J., et al. Evaluation of Etest and disk diffusion methods compared with broth microdilution antifungal susceptibility testing of clinical isolates of Candida spp. against posaconazole 2007, 45:1974-1977.
13. Espinel-Ingroff E.Canton, Gibbs D., Wang A. Correlation of neo-sensitabs tablet diffusion assay results on three different agar media with CLSI broth microdilution M27-A2 and disk diffusion M44-A results for testing susceptibilities of Candida spp. and Cryptococcus neoformans to amphotericin B, caspofungin, fluconazole, itraconazole, and voriconazole. J. Clin. Microbiol. 2007, 45:858-864.
14. Gokce G., Cerikcioglu N., Yagci A. Acid proteinase, phospholipase, and biofilm production of Candida species isolated from blood cultures. Mycopathologia 2007, 164:265-269.
15. Gross N.T., Arias L.M., Moraga M., Baddasarow Y., Jarstrand C. Species Distribution and Susceptibility to Azoles of Vaginal Yeasts Isolated Prostitutes. Infectious Diseases in Obstetrics and Gynecology Volume 2 Article ID 82412, 5 pages 2007.
16. Kiraz N., Daǧ I., Yamac M., Kiremitci A., Kaşifoǧlu N., Akgun Y. Antifungal activity of caspofungin in combination with amphotericin B against Candida glabrata: comparison of disk diffusion, etest, and time-kill methods. Antimicrob. Agents Chemother. 2009, 53:788-790.
17. Koehler A.P., CHU K., Houang E.S., Cheng A.F. Simple, reliable, and cost-effective yeast identification scheme for the clinical laboratory. J. Clin. Microbiol. 1999, 37:422-426.
18. Koç A.N., Gökahmetoǧlu S., Oǧuzkaya M. Comparison of E test with the broth susceptibilities of yeast isolates. Mycoses 2000, 43:293-297.
19. Lass-Flörl C., Perkhofer S., Mayr A. In vitro susceptibility testing in fungi: a global perspective on a variety of methods. Mycoses 2009, 53:1-11.
20. Lupetti A., Danesi R., Campa M., Tacca M.D., Kelly S. Molecular basis of resistance to azole antifungals. Trends Mol. Med. 2002, 8:76-81.
21. Matar M., Ostrosky-Zeichner L., Paetznick V.L., Rodriguez J.R., Chen E., Rex J.H. Correlation between Etest, disk diffusion, and microdilution methods for antifungal susceptibility testing of fluconazole and voriconazole. Antimicrob. Agents Chemother. 2003, 47:1647-1651.
22. Milici M.E., Maida C.M., Spreghini E., Ravazzolo B., Oliveri S., Scalise G., et al. Comparison between disk diffusion and microdilution methods for determining susceptibility of clinical fungal isolates to caspofungin. J. Clin. Microbiol. 2007, 45:3529-3533.
23. Ostrosky-Zeichner L., Rex J.H., Pappas P.G., Hamill R.J., Larsen R.A., Horowitz H.W., et al. Antifungal susceptibility survey of 2,000 bloodstream Candida isolates in the United States. Antimicrob. Agents Chemother. 2003, 47:3149-3154.
24. Pfaller M.A., Hazen K.C., Messer S.A., Boyken L., Tendolkar S., Hollis R.J., et al. Comparison of results of fluconazole disk diffusion testing for Candida species with results from a Central Reference Laboratory in the ARTEMIS Global Antifungal Surveillance Program. J. Clin. Microbiol. 2004, 42:3607-3612.
25. Posteraro B., Martucci R., La Sorda M., Fiori B., Sanglard D., De Carolis E., et al. Reliability of the Vitek 2 yeast susceptibility test for detection of in vitro resistance to fluconazole and voriconazole in clinical isolates of Candida albicans and Candida glabrata. J. Clin. Microbiol. 2009, 47:1927-1930.
26. Rubio M.C., Gil J., Ocáriz I.R., Benito R., Rezusta A. Comparison of results obtained by testing with three different agar media and by the NCCLS M27-A method for in vitro testing of fluconazole against Candida spp. Clin. Microbiol. 2003, 41:2665-2668.
27. Sandven P. Detection of fluconazole-resistant Candida strains by a disc diffusion screening test. J. Clin. Microbiol. 1999, 37:3856-3859.
28. Sanguinetti M., Posteraro B., Fiori B., Ranno S., Torelli R., Fadda F. Mechanisms of azole resistance in clinical isolates of Candida glabrata collected during a hospital survey of antifungal resistance. Antimicrob. Agents Chemother. 2005, 49(668-679):49.
29. Sims C.R., Paetznick V.L., Rodriguez J.R., Chen E., Ostrosky-Zeichner L. Correlation between microdilution, E-test, and disk diffusion methods for antifungal susceptibility testing of posaconazole against Candida spp. J. Clin. Microbiol. 2006, 44:2105-2108.
30. Yumi Koga-Ito C., Lyon J.P., Resende M.A. Comparison between E-test and CLSI broth microdilution method for antifungal susceptibility testing of Candida albicans oral isolates. Rev. Inst. Med. Trop. S. Paulo. 2008, 50:7-10.